Olayinka Aiyegoro

Dr. Olayinka Aiyegoro


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2010 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
OAOlayinka Aiyegoro
Olayinka Aiyegoro
AOAnthony Okoh
Anthony Okoh
Many oxidative stress related diseases are as a result of accumulation of free radicals in the body. A lot of researches are going on worldwide directed towards finding natural antioxidants of plants origins. The aims of this study were to evaluate in vitro antioxidant activities and to screen for phytochemical constituents of Helichrysum longifolium DC. [Family Asteraceae] aqueous crude extract.

13 April 2021 in Biology
Verified
Journal Article
Open access
PDF file
IKIliya D. Kwoji
Iliya D. Kwoji
OAOlayinka Aiyegoro
Olayinka Aiyegoro
MOMoses Okpeku
Moses Okpeku
MAMatthew Adekunle Adeleke
Matthew Adekunle Adeleke
The use of probiotics for health benefits is becoming popular because of the quest for safer products with protective and therapeutic effects against diseases and infectious agents. The emergence and spread of antimicrobial resistance among pathogens had prompted restrictions over the non-therapeutic use of antibiotics for prophylaxis and growth promotion, especially in animal husbandry. While single-strain probiotics are beneficial to health, multi-strain probiotics might be more helpful because of synergy and additive effects among the individual isolates. This article documents the mechanisms by which multi-strain probiotics exert their effects in managing infectious and non-infectious diseases, inhibiting antibiotic-resistant pathogens and health improvement. The administration of multi-strain probiotics was revealed to effectively alleviate bowel tract conditions, such as irritable bowel syndrome, inhibition of pathogens and modulation of the immune system and gut microbiota. Finally, while most of the current research focuses on comparing the effects of multi-strain and single-strain probiotics, there is a dearth of information on the molecular mechanisms of synergy among multi-strain probiotics isolates. This forms a basis for future research in the development of multi-strain probiotics for enhanced health benefits.

6 March 2017 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
SOSunday Oyedemi
Sunday Oyedemi
BOBlessing O. Oyedemi
Blessing O. Oyedemi
Ifeoma IjehIfeoma Ijeh
Ifeoma Ijeh
POPrincemartins E. Ohanyerem
Princemartins E. Ohanyerem
RCRoger M Coopoosamy
Roger M Coopoosamy
OAOlayinka Aiyegoro
Olayinka Aiyegoro
Oxidative stress plays a significant role in the pathogenesis of metabolic syndrome including diabetes mellitus (DM). The inhibition of alpha-amylase is an important therapeutic target in the regulation of postprandial increase of blood glucose in diabetic patients. The present study investigated the alpha-amylase inhibitory and antioxidant potential of selected herbal drugs used in the treatment of DM by the traditional healers in Isiala Mbano and Ikwuano regions of southeastern Nigeria. Antioxidant activity was evaluated in terms of free radical scavenging, reducing power, and total phenolic (TPC) and flavonoid content (TFC) in consonance with the TLC profiling. The results showed that methanol crude extracts fromAnacardium occidentale(AO) andCeiba pentandra(CP) recorded higher TPC and TFC, potent free radical scavenging, and efficient reducing power (RP) as compared with other plant samples. All the plant extracts exhibited a relative alpha-amylase inhibition apart fromStrophanthus hispidus(SH) extract with a negative effect. We discovered a mild to weak correlation between alpha-amylase inhibition or antioxidative capacity and the total phenol or flavonoid content. At least in part, the results obtained in this work support the traditional use of certain plant species in the treatment of patients with DM.

5 April 2020 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
TMTshifhiwa Paris Mamphogoro
Tshifhiwa Paris Mamphogoro
Olubukola Oluranti BabalolaOlubukola Oluranti Babalola
Olubukola Oluranti Babalola
OAOlayinka Aiyegoro
Olayinka Aiyegoro
Pepper bacterial wilt is caused by the bacterial pathogen, Ralstonia solanacearum. It is the most destructive disease of many Solanaceous crops such as potatoes, tobacco, pepper, tomatoes, and eggplant and is a significant source of crop loss worldwide. Physical, cultural and chemical controls have been employed to combat this destructive disease. However, none of these strategies has been able to control the disease completely due to the broad host range and genetic diversity of the pathogen, its prolonged survival in the soil and survival on vegetation as a latent infection. Owing to co‐management strategies, biological control is the best approach for human health and environmental friendly motivations. It makes use of various antagonistic rhizobacteria and epiphytic species such as Bacillus cereus, Pseudomonas putida, Bacillus subtilis, Paenibacillus macerans, Serratia marcescens, Bacillus pumilus and Pseudomonas fluorescens, which compete with and ultimately inhibit the growth of the pathogen. The possible mechanisms of bio‐control by these species involve multifaceted interactions between the host, pathogen and the antagonists. These can involve competition for nutrients and space, plant‐mediated systemic resistance, siderophore production, and production of extracellular cell wall degrading enzymes to inhibit or suppress the growth of the bacterial wilt agent.

7 June 2018 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
ZDZiyanda C. Dlamini
Ziyanda C. Dlamini
RLRashwahla L. S. Langa
Rashwahla L. S. Langa
OAOlayinka Aiyegoro
Olayinka Aiyegoro
AOAnthony Okoh
Anthony Okoh

4 February 2020 in Sustainability
Verified
Journal Article
Open access
PDF file
KAKazeem Adekunle Alayande
Kazeem Adekunle Alayande
OAOlayinka Aiyegoro
Olayinka Aiyegoro
CACollins Ateba
Collins Ateba
Probiotics have been emerging as a safe and viable alternative to antibiotics for increasing performance in livestock. Literature was collated via retrieved information from online databases, viz, PubMed, MEDLINE, ScienceDirect, Scopus, Web of Science and Google Scholar. Besides improved immunomodulation and nutrient digestibility, in-feed probiotics have shown drastic reductions in gastrointestinal tract-invading pathogens. However, every novel probiotic strain cannot be assumed to share historical safety with conventional strains. Any strain not belonging to the wild-type distributions of relevant antimicrobials, or found to be harbouring virulence determinants, should not be developed further. Modes of identification and the transmigration potential of the strains across the gastrointestinal barrier must be scrutinized. Other potential risk factors include the possibility of promoting deleterious metabolic effects, excessive immune stimulation and genetic stability of the strains over time. Adverse effects of probiotics could be strain specific, depending on the prevailing immunological and physiological condition of the host. The most crucial concern is the stability of the strain. Probiotics stand a good chance of replacing antibiotics in animal husbandry. The possibility of the probiotics used in animal feed cross-contaminating the human food chain cannot be downplayed. Thus, the established safety measures in probiotic development must be adhered to for a successful global campaign on food safety and security.
1